instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Erythema'? | Dermatological manifestations during COVID-19 infection: a case series and discussion on the problem of differential diagnosis.
On March 11, 2019 the World Health Organization (WHO) declared Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, as a pandemic. As of 15/01/2021, more than ninety million cases of inf... | Recovered | ReactionOutcome | CC BY-NC-SA | 33682815 | 19,169,148 | 2021-02-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Basal cell carcinoma'. | A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
BI 836826 is a chimeric immunoglobulin G1 antibody targeting CD37, a transmembrane protein expressed on normal and malignant B c... | IBRUTINIB | DrugsGivenReaction | CC BY | 33683501 | 19,065,111 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'CD4 lymphocytes decreased'. | A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
BI 836826 is a chimeric immunoglobulin G1 antibody targeting CD37, a transmembrane protein expressed on normal and malignant B c... | IBRUTINIB | DrugsGivenReaction | CC BY | 33683501 | 19,065,111 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
BI 836826 is a chimeric immunoglobulin G1 antibody targeting CD37, a transmembrane protein expressed on normal and malignant B c... | IBRUTINIB | DrugsGivenReaction | CC BY | 33683501 | 19,065,111 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
BI 836826 is a chimeric immunoglobulin G1 antibody targeting CD37, a transmembrane protein expressed on normal and malignant B c... | IBRUTINIB | DrugsGivenReaction | CC BY | 33683501 | 19,065,111 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
BI 836826 is a chimeric immunoglobulin G1 antibody targeting CD37, a transmembrane protein expressed on normal and malignant B c... | IBRUTINIB | DrugsGivenReaction | CC BY | 33683501 | 19,065,111 | 2021-08 |
What was the administration route of drug 'IBRUTINIB'? | A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
BI 836826 is a chimeric immunoglobulin G1 antibody targeting CD37, a transmembrane protein expressed on normal and malignant B c... | Oral | DrugAdministrationRoute | CC BY | 33683501 | 19,065,111 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain stem infarction'. | Emergent stenting after intravenous thrombolysis for isolated basilar artery dissection in a patient with acute ischemic stroke: a case report.
BACKGROUND
Isolated basilar artery dissection (IBAD) is a rare but important cause of ischemic stroke. Anti-thrombotic therapy is often used to treat IBAD-related ischemic stro... | ALTEPLASE | DrugsGivenReaction | CC BY | 33685504 | 19,051,578 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vertebral artery dissection'. | Emergent stenting after intravenous thrombolysis for isolated basilar artery dissection in a patient with acute ischemic stroke: a case report.
BACKGROUND
Isolated basilar artery dissection (IBAD) is a rare but important cause of ischemic stroke. Anti-thrombotic therapy is often used to treat IBAD-related ischemic stro... | ALTEPLASE | DrugsGivenReaction | CC BY | 33685504 | 19,051,578 | 2021-03-09 |
What was the administration route of drug 'ALTEPLASE'? | Emergent stenting after intravenous thrombolysis for isolated basilar artery dissection in a patient with acute ischemic stroke: a case report.
BACKGROUND
Isolated basilar artery dissection (IBAD) is a rare but important cause of ischemic stroke. Anti-thrombotic therapy is often used to treat IBAD-related ischemic stro... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33685504 | 19,051,578 | 2021-03-09 |
What was the outcome of reaction 'Vertebral artery dissection'? | Emergent stenting after intravenous thrombolysis for isolated basilar artery dissection in a patient with acute ischemic stroke: a case report.
BACKGROUND
Isolated basilar artery dissection (IBAD) is a rare but important cause of ischemic stroke. Anti-thrombotic therapy is often used to treat IBAD-related ischemic stro... | Recovering | ReactionOutcome | CC BY | 33685504 | 19,051,578 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device dislocation'. | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | LEVONORGESTREL | DrugsGivenReaction | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | LEVONORGESTREL | DrugsGivenReaction | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Embedded device'. | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | LEVONORGESTREL | DrugsGivenReaction | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ruptured ectopic pregnancy'. | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | LEVONORGESTREL | DrugsGivenReaction | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Uterine perforation'. | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | LEVONORGESTREL | DrugsGivenReaction | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
What was the administration route of drug 'LEVONORGESTREL'? | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | Intra-uterine | DrugAdministrationRoute | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
What was the outcome of reaction 'Device dislocation'? | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | Recovered | ReactionOutcome | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
What was the outcome of reaction 'Embedded device'? | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | Recovered | ReactionOutcome | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
What was the outcome of reaction 'Ruptured ectopic pregnancy'? | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | Recovered | ReactionOutcome | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
What was the outcome of reaction 'Uterine perforation'? | Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
BACKGROUND
The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively ... | Recovered | ReactionOutcome | CC BY | 33685513 | 19,041,622 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aggression'. | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | ARIPIPRAZOLE, BISOPROLOL, CITALOPRAM HYDROBROMIDE, DIGOXIN, MIRTAZAPINE, NITROGLYCERIN, QUETIAPINE FUMARATE | DrugsGivenReaction | CC BY-NC | 33685912 | 19,993,400 | 2021-03-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | ARIPIPRAZOLE, BISOPROLOL, CITALOPRAM HYDROBROMIDE, DIGOXIN, MIRTAZAPINE, NITROGLYCERIN, QUETIAPINE FUMARATE | DrugsGivenReaction | CC BY-NC | 33685912 | 19,993,400 | 2021-03-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Memory impairment'. | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | ARIPIPRAZOLE, BISOPROLOL, CITALOPRAM HYDROBROMIDE, DIGOXIN, MIRTAZAPINE, NITROGLYCERIN, QUETIAPINE FUMARATE | DrugsGivenReaction | CC BY-NC | 33685912 | 19,993,400 | 2021-03-08 |
What was the administration route of drug 'APIXABAN'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Oral | DrugAdministrationRoute | CC BY-NC | 33685912 | 19,421,458 | 2021-03-08 |
What was the administration route of drug 'LORAZEPAM'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Intramuscular | DrugAdministrationRoute | CC BY-NC | 33685912 | 19,421,458 | 2021-03-08 |
What was the administration route of drug 'RIVAROXABAN'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Oral | DrugAdministrationRoute | CC BY-NC | 33685912 | 19,024,234 | 2021-03-08 |
What was the administration route of drug 'ZUCLOPENTHIXOL'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Oral | DrugAdministrationRoute | CC BY-NC | 33685912 | 19,052,008 | 2021-03-08 |
What was the outcome of reaction 'Aggression'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Recovering | ReactionOutcome | CC BY-NC | 33685912 | 19,993,400 | 2021-03-08 |
What was the outcome of reaction 'Agitation'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Recovering | ReactionOutcome | CC BY-NC | 33685912 | 19,993,400 | 2021-03-08 |
What was the outcome of reaction 'Condition aggravated'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Recovering | ReactionOutcome | CC BY-NC | 33685912 | 19,422,277 | 2021-03-08 |
What was the outcome of reaction 'Memory impairment'? | Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starti... | Recovering | ReactionOutcome | CC BY-NC | 33685912 | 19,993,400 | 2021-03-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acquired gene mutation'. | Monitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
Osimertinib is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that is effective in treating both naïve and ... | OSIMERTINIB | DrugsGivenReaction | CC BY-NC | 33686722 | 19,711,823 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Monitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
Osimertinib is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that is effective in treating both naïve and ... | OSIMERTINIB | DrugsGivenReaction | CC BY-NC | 33686722 | 19,711,823 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant transformation'. | Monitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
Osimertinib is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that is effective in treating both naïve and ... | OSIMERTINIB | DrugsGivenReaction | CC BY-NC | 33686722 | 19,711,823 | 2021-06 |
What was the administration route of drug 'OSIMERTINIB'? | Monitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
Osimertinib is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that is effective in treating both naïve and ... | Oral | DrugAdministrationRoute | CC BY-NC | 33686722 | 19,711,823 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Use of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula.
Coronavirus disease-2019 (COVID-19) pneumonia is one of the severe and most dreaded forms of illness caused by severe acute respiratory syndrome coronavirus 2. It often progresses to respiratory failure and ... | REMDESIVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 33686984 | 20,932,243 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Use of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula.
Coronavirus disease-2019 (COVID-19) pneumonia is one of the severe and most dreaded forms of illness caused by severe acute respiratory syndrome coronavirus 2. It often progresses to respiratory failure and ... | REMDESIVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 33686984 | 20,932,243 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Central nervous system lesion'. | Miliary tuberculosis in a paediatric patient with psoriasis.
We present a 16-year-old girl with a history of well-controlled psoriasis, on immunosuppression, who sought evaluation in the emergency department for 4 months of fever, cough and unintentional weight loss. The patient had seen multiple providers who had diag... | METHOTREXATE | DrugsGivenReaction | CC BY-NC | 33687934 | 19,840,401 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disseminated tuberculosis'. | Miliary tuberculosis in a paediatric patient with psoriasis.
We present a 16-year-old girl with a history of well-controlled psoriasis, on immunosuppression, who sought evaluation in the emergency department for 4 months of fever, cough and unintentional weight loss. The patient had seen multiple providers who had diag... | METHOTREXATE | DrugsGivenReaction | CC BY-NC | 33687934 | 19,840,401 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Miliary tuberculosis in a paediatric patient with psoriasis.
We present a 16-year-old girl with a history of well-controlled psoriasis, on immunosuppression, who sought evaluation in the emergency department for 4 months of fever, cough and unintentional weight loss. The patient had seen multiple providers who had diag... | METHOTREXATE | DrugsGivenReaction | CC BY-NC | 33687934 | 19,840,401 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palpitations'. | Miliary tuberculosis in a paediatric patient with psoriasis.
We present a 16-year-old girl with a history of well-controlled psoriasis, on immunosuppression, who sought evaluation in the emergency department for 4 months of fever, cough and unintentional weight loss. The patient had seen multiple providers who had diag... | METHOTREXATE | DrugsGivenReaction | CC BY-NC | 33687934 | 19,840,401 | 2021-03-09 |
What was the dosage of drug 'METHOTREXATE'? | Miliary tuberculosis in a paediatric patient with psoriasis.
We present a 16-year-old girl with a history of well-controlled psoriasis, on immunosuppression, who sought evaluation in the emergency department for 4 months of fever, cough and unintentional weight loss. The patient had seen multiple providers who had diag... | UNKNOWN | DrugDosageText | CC BY-NC | 33687934 | 19,840,401 | 2021-03-09 |
What was the outcome of reaction 'Disseminated tuberculosis'? | Miliary tuberculosis in a paediatric patient with psoriasis.
We present a 16-year-old girl with a history of well-controlled psoriasis, on immunosuppression, who sought evaluation in the emergency department for 4 months of fever, cough and unintentional weight loss. The patient had seen multiple providers who had diag... | Recovering | ReactionOutcome | CC BY-NC | 33687934 | 19,840,401 | 2021-03-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.
Human epidermal growth factor receptor2 (HER2) overexpression/amplification is associated with high malignancy, rapid disease pr... | EPIRUBICIN HYDROCHLORIDE, LAPATINIB | DrugsGivenReaction | CC BY-NC | 33688205 | 19,110,981 | 2021 |
What was the administration route of drug 'EPIRUBICIN HYDROCHLORIDE'? | Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.
Human epidermal growth factor receptor2 (HER2) overexpression/amplification is associated with high malignancy, rapid disease pr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33688205 | 19,110,981 | 2021 |
What was the administration route of drug 'LAPATINIB'? | Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.
Human epidermal growth factor receptor2 (HER2) overexpression/amplification is associated with high malignancy, rapid disease pr... | Oral | DrugAdministrationRoute | CC BY-NC | 33688205 | 19,110,981 | 2021 |
What was the dosage of drug 'EPIRUBICIN HYDROCHLORIDE'? | Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.
Human epidermal growth factor receptor2 (HER2) overexpression/amplification is associated with high malignancy, rapid disease pr... | 80 MG/M2, CYCLIC (DAY 1 EVERY 21 DAYS) | DrugDosageText | CC BY-NC | 33688205 | 19,110,981 | 2021 |
What was the dosage of drug 'LAPATINIB'? | Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.
Human epidermal growth factor receptor2 (HER2) overexpression/amplification is associated with high malignancy, rapid disease pr... | 0.25 G, 1X/DAY | DrugDosageText | CC BY-NC | 33688205 | 19,110,981 | 2021 |
What was the outcome of reaction 'Hepatic function abnormal'? | Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.
Human epidermal growth factor receptor2 (HER2) overexpression/amplification is associated with high malignancy, rapid disease pr... | Recovering | ReactionOutcome | CC BY-NC | 33688205 | 19,110,981 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palmar-plantar erythrodysaesthesia syndrome'. | Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study.
To evaluate the efficacy and safety of neoadjuvant chemotherapy with albumin-bound... | CAPECITABINE, CISPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33688259 | 19,063,857 | 2021 |
What was the administration route of drug 'PACLITAXEL'? | Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study.
To evaluate the efficacy and safety of neoadjuvant chemotherapy with albumin-bound... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 33688259 | 19,063,857 | 2021 |
What was the dosage of drug 'CAPECITABINE'? | Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study.
To evaluate the efficacy and safety of neoadjuvant chemotherapy with albumin-bound... | 3500 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC | 33688259 | 19,063,857 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | CMV Pancreatitis in an Immunocompromised Patient.
Cytomegalovirus (CMV) is a common double-stranded DNA (dsDNA) virus affecting a large majority of the world's population. In immunocompetent patients, CMV infection can range anywhere from an asymptomatic course to mononucleosis. However, in the immunocompromised patien... | AMIKACIN, CEFEPIME HYDROCHLORIDE, CIPROFLOXACIN, GANCICLOVIR, MEROPENEM, METRONIDAZOLE, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 33688440 | 19,030,299 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | CMV Pancreatitis in an Immunocompromised Patient.
Cytomegalovirus (CMV) is a common double-stranded DNA (dsDNA) virus affecting a large majority of the world's population. In immunocompetent patients, CMV infection can range anywhere from an asymptomatic course to mononucleosis. However, in the immunocompromised patien... | AMIKACIN, CEFEPIME HYDROCHLORIDE, CIPROFLOXACIN, GANCICLOVIR, MEROPENEM, METRONIDAZOLE, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 33688440 | 19,030,299 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | CMV Pancreatitis in an Immunocompromised Patient.
Cytomegalovirus (CMV) is a common double-stranded DNA (dsDNA) virus affecting a large majority of the world's population. In immunocompetent patients, CMV infection can range anywhere from an asymptomatic course to mononucleosis. However, in the immunocompromised patien... | AMIKACIN, CEFEPIME HYDROCHLORIDE, CIPROFLOXACIN, GANCICLOVIR, MEROPENEM, METRONIDAZOLE, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 33688440 | 19,030,299 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | CMV Pancreatitis in an Immunocompromised Patient.
Cytomegalovirus (CMV) is a common double-stranded DNA (dsDNA) virus affecting a large majority of the world's population. In immunocompetent patients, CMV infection can range anywhere from an asymptomatic course to mononucleosis. However, in the immunocompromised patien... | Not recovered | ReactionOutcome | CC BY | 33688440 | 19,030,299 | 2021 |
What was the outcome of reaction 'Renal impairment'? | CMV Pancreatitis in an Immunocompromised Patient.
Cytomegalovirus (CMV) is a common double-stranded DNA (dsDNA) virus affecting a large majority of the world's population. In immunocompetent patients, CMV infection can range anywhere from an asymptomatic course to mononucleosis. However, in the immunocompromised patien... | Not recovered | ReactionOutcome | CC BY | 33688440 | 19,030,299 | 2021 |
What was the administration route of drug 'DEXMEDETOMIDINE HYDROCHLORIDE'? | Dexmedetomidine Induced Polyuria in the Intensive Care Unit.
Dexmedetomidine is an α2-adrenergic used as an adjunct therapy for sedation in the intensive care unit. While it is known to cause polyuria exclusively in perioperative conditions, not many cases are known in the intensive care unit, thus making the diagnosis... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33688441 | 19,190,517 | 2021 |
What was the administration route of drug 'DEXMEDETOMIDINE'? | Dexmedetomidine Induced Polyuria in the Intensive Care Unit.
Dexmedetomidine is an α2-adrenergic used as an adjunct therapy for sedation in the intensive care unit. While it is known to cause polyuria exclusively in perioperative conditions, not many cases are known in the intensive care unit, thus making the diagnosis... | Intravenous drip | DrugAdministrationRoute | CC BY | 33688441 | 19,218,312 | 2021 |
What was the outcome of reaction 'Off label use'? | Dexmedetomidine Induced Polyuria in the Intensive Care Unit.
Dexmedetomidine is an α2-adrenergic used as an adjunct therapy for sedation in the intensive care unit. While it is known to cause polyuria exclusively in perioperative conditions, not many cases are known in the intensive care unit, thus making the diagnosis... | Recovered | ReactionOutcome | CC BY | 33688441 | 19,190,517 | 2021 |
What was the outcome of reaction 'Polyuria'? | Dexmedetomidine Induced Polyuria in the Intensive Care Unit.
Dexmedetomidine is an α2-adrenergic used as an adjunct therapy for sedation in the intensive care unit. While it is known to cause polyuria exclusively in perioperative conditions, not many cases are known in the intensive care unit, thus making the diagnosis... | Recovered | ReactionOutcome | CC BY | 33688441 | 19,168,544 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | ACETAMINOPHEN, AMLODIPINE BESYLATE, AZTREONAM, CLINDAMYCIN, CLOZAPINE, DOCUSATE, GENTAMICIN, OLANZAPINE, POLYETHYLENE GLYCOLS, RISPERIDONE, VALPROATE SODIUM | DrugsGivenReaction | CC BY | 33688445 | 19,142,002 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | ACETAMINOPHEN, AMLODIPINE BESYLATE, AZTREONAM, CLINDAMYCIN, CLOZAPINE, DOCUSATE, FILGRASTIM, GENTAMICIN, OLANZAPINE, POLYETHYLENE GLYCOLS, RISPERIDONE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33688445 | 19,084,247 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level below therapeutic'. | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | AMLODIPINE BESYLATE, CLOZAPINE, DOCUSATE, OLANZAPINE, POLYETHYLENE GLYCOLS, RISPERIDONE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33688445 | 19,037,229 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Potentiating drug interaction'. | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | AMLODIPINE BESYLATE, CLOZAPINE, DOCUSATE, OLANZAPINE, POLYETHYLENE GLYCOLS, RISPERIDONE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33688445 | 19,037,229 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | ACETAMINOPHEN, AMLODIPINE BESYLATE, AZTREONAM, CLINDAMYCIN, CLOZAPINE, DOCUSATE, GENTAMICIN, OLANZAPINE, POLYETHYLENE GLYCOLS, RISPERIDONE, VALPROATE SODIUM | DrugsGivenReaction | CC BY | 33688445 | 19,142,002 | 2021 |
What was the administration route of drug 'CLOZAPINE'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | Oral | DrugAdministrationRoute | CC BY | 33688445 | 19,084,247 | 2021 |
What was the administration route of drug 'FILGRASTIM'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | Subcutaneous | DrugAdministrationRoute | CC BY | 33688445 | 19,084,247 | 2021 |
What was the dosage of drug 'AZTREONAM'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | CONTINUED TILL TREATMENT DAY 6 | DrugDosageText | CC BY | 33688445 | 19,084,247 | 2021 |
What was the dosage of drug 'CLINDAMYCIN'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | CONTINUED TILL TREATMENT DAY 6 | DrugDosageText | CC BY | 33688445 | 19,084,247 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | Recovering | ReactionOutcome | CC BY | 33688445 | 19,142,002 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | Recovering | ReactionOutcome | CC BY | 33688445 | 19,084,247 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | Recovering | ReactionOutcome | CC BY | 33688445 | 19,084,247 | 2021 |
What was the outcome of reaction 'Potentiating drug interaction'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | Recovered | ReactionOutcome | CC BY | 33688445 | 19,037,229 | 2021 |
What was the outcome of reaction 'Renal failure'? | Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis.
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophre... | Recovering | ReactionOutcome | CC BY | 33688445 | 19,142,002 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | ANAKINRA, ASCORBIC ACID, CHLOROQUINE, THIAMINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33688601 | 19,910,563 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gangrene'. | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | AMIODARONE, ANAKINRA, ARGATROBAN, ASCORBIC ACID, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CHLOROQUINE, EPINEPHRINE, HEPARIN SODIUM, METHYLPREDNISOLONE, NOREPINEPHRINE, PHENYLEPHRINE HYDROCHLORIDE, POVIDONE-IODINE, THIAMINE | DrugsGivenReaction | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | ANAKINRA, ASCORBIC ACID, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CHLOROQUINE, THIAMINE | DrugsGivenReaction | CC BY-NC-ND | 33688601 | 19,911,071 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | AMIODARONE, ANAKINRA, ARGATROBAN, ASCORBIC ACID, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CHLOROQUINE, EPINEPHRINE, HEPARIN SODIUM, METHYLPREDNISOLONE, NOREPINEPHRINE, PHENYLEPHRINE HYDROCHLORIDE, POVIDONE-IODINE, THIAMINE | DrugsGivenReaction | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | ANAKINRA, ARGATROBAN, ASCORBIC ACID, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CHLOROQUINE, EPINEPHRINE, HEPARIN SODIUM, METHYLPREDNISOLONE, NOREPINEPHRINE, PHENYLEPHRINE HYDROCHLORIDE, THIAMINE | DrugsGivenReaction | CC BY-NC-ND | 33688601 | 19,933,808 | 2021-06 |
What was the administration route of drug 'AMIODARONE'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | Other | DrugAdministrationRoute | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
What was the administration route of drug 'EPINEPHRINE'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | Other | DrugAdministrationRoute | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
What was the dosage of drug 'EPINEPHRINE'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | INFUSION FOR 30 DAYS | DrugDosageText | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
What was the dosage of drug 'HEPARIN SODIUM'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | UNK, CONTINUOUS INFUSION | DrugDosageText | CC BY-NC-ND | 33688601 | 19,933,808 | 2021-06 |
What was the dosage of drug 'NOREPINEPHRINE'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | FOR 30 DAYS | DrugDosageText | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
What was the dosage of drug 'PHENYLEPHRINE HYDROCHLORIDE'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | FOR 30 DAYS | DrugDosageText | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
What was the outcome of reaction 'Dry gangrene'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | Recovered | ReactionOutcome | CC BY-NC-ND | 33688601 | 19,933,808 | 2021-06 |
What was the outcome of reaction 'Gangrene'? | Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation.
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation. However, this combination can result i... | Recovering | ReactionOutcome | CC BY-NC-ND | 33688601 | 19,951,856 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study.
BACKGROUND
Incomplete suicidality coding in administrative claims data is a known obstacle for observational studies. With most of the negative outcomes missing from t... | ARIPIPRAZOLE | DrugsGivenReaction | CC BY | 33688834 | 19,918,177 | 2021-04-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse drug reaction'. | Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Pathologic complete response is associated with longer disease-free survival and better overall survival after neoadjuvant chemotherapy in breast cancer patients. We, therefore, evaluated factors influencing pathologic ... | CARBOPLATIN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33689016 | 19,047,528 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytopenia'. | Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Pathologic complete response is associated with longer disease-free survival and better overall survival after neoadjuvant chemotherapy in breast cancer patients. We, therefore, evaluated factors influencing pathologic ... | CARBOPLATIN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33689016 | 19,047,528 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Pathologic complete response is associated with longer disease-free survival and better overall survival after neoadjuvant chemotherapy in breast cancer patients. We, therefore, evaluated factors influencing pathologic ... | CARBOPLATIN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33689016 | 19,047,528 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Pathologic complete response is associated with longer disease-free survival and better overall survival after neoadjuvant chemotherapy in breast cancer patients. We, therefore, evaluated factors influencing pathologic ... | CARBOPLATIN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33689016 | 19,047,528 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Pathologic complete response is associated with longer disease-free survival and better overall survival after neoadjuvant chemotherapy in breast cancer patients. We, therefore, evaluated factors influencing pathologic ... | CARBOPLATIN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33689016 | 19,047,528 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Polyneuropathy'. | Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Pathologic complete response is associated with longer disease-free survival and better overall survival after neoadjuvant chemotherapy in breast cancer patients. We, therefore, evaluated factors influencing pathologic ... | CARBOPLATIN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33689016 | 19,047,528 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report.
The incidence of patients with liver cirrhosis (LC) is increasing. Patients with LC are known to have a greater risk of postoperative morbidity and mortality than patients without... | GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR | DrugsGivenReaction | CC BY | 33689973 | 19,088,732 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to liver'. | Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report.
The incidence of patients with liver cirrhosis (LC) is increasing. Patients with LC are known to have a greater risk of postoperative morbidity and mortality than patients without... | GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR | DrugsGivenReaction | CC BY | 33689973 | 19,088,732 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report.
The incidence of patients with liver cirrhosis (LC) is increasing. Patients with LC are known to have a greater risk of postoperative morbidity and mortality than patients without... | GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR | DrugsGivenReaction | CC BY | 33689973 | 19,088,732 | 2021-04 |
What is the weight of the patient? | Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report.
The incidence of patients with liver cirrhosis (LC) is increasing. Patients with LC are known to have a greater risk of postoperative morbidity and mortality than patients without... | 60 kg. | Weight | CC BY | 33689973 | 19,088,732 | 2021-04 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.